Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Study of ctDNA Guided Change in Treatment for Refractory Minimal Residual Disease in Colon Adenocarcinomas

NCT04920032 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT04920032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Study of ctDNA Guided Change in Treatment for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Lead sponsor
University of California, Irvine
Phase
Phase 1
Overall status
Recruiting
Start date
August 26, 2021
Completion date
January 21, 2028
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenocarcinoma, colorectal cancer